Selexis CHO Cells in Suspension-1

Archives 2020

Selexis has been setting the pace of innovation in protein expression and establishing new benchmarks in bioproduction for  two decades.

 

OCTOBER 20, 2020
6 min read

JSR Life Sciences Expands its European Gene-to-GMP Biologics Manufacturing Facilities for Selexis and KBI Biopharma in Geneva, Switzerland

SUNNYVALE, California, October 20, 2020JSR Life Sciences, LLC today announced that it is increasing its European...

Read More
OCTOBER 16, 2020
4 min read

Selexis Names Biopharmaceutical Executive Dirk Lange as New Chief Executive Officer

Geneva, Switzerland, October 16, 2020Selexis SA, a JSR Life Sciences Company, today announced the appointment of...

Read More
SEPTEMBER 2, 2020
4 min read

Igyxos and Selexis Enter Service Agreement to Advance Igyxos’ First-In-Class Monoclonal Antibody for the Treatment of Human Infertility

Geneva, Switzerland, and Nouzilly, France, September 2, 2020  Selexis SA and Igyxos announced today that they have...

Read More
MAY 19, 2020
3 min read

Selexis Expands Scientific and Operational Leadership Teams with Key Promotions

Geneva, Switzerland, May 19, 2020Selexis SA, a JSR Life Sciences Company, today announced key promotions across its...

Read More
APRIL 21, 2020
3 min read

Great Place to Work® Certifies Selexis as a 2020 Best Workplace in Switzerland for Third Year In a Row

Geneva, Switzerland, April 21, 2020Selexis SA, a JSR Life Sciences Company, announced today that Great Place to Work®

Read More
FEBRUARY 11, 2020
3 min read

Women In Bio Names Selexis Director of Business Development and Licensing Jessica Bosc as President

Geneva, Switzerland, February 11, 2020Selexis SA, a JSR Life Sciences Company, today announced that Women In Bio...

Read More
JANUARY 29, 2020
2 min read

Meet with Selexis Scientific and Business Leaders at Upcoming Industry Conferences

Geneva, Switzerland, January 29, 2020Selexis SA, a JSR Life Sciences Company, today announced its planned...

Read More
JANUARY 9, 2020
3 min read

Selexis Promotes Dr. Yemi Onakunle to Chief Business Officer

Industry Expert with 20+ Years’ Experience in Biopharmaceutical Drug Development and Manufacturing Now Leading...

Read More